1. Metabolomics-Guided Discovery of Microginin Peptides from Cultures of the Cyanobacterium Microcystis aeruginosa
- Author
-
Rudravajhala Ravindra, Allison K. Stewart, Ryan M. Van Wagoner, and Jeffrey L. C. Wright
- Subjects
0301 basic medicine ,Microcystis ,Pharmaceutical Science ,Peptide ,Angiotensin-Converting Enzyme Inhibitors ,Tripeptide ,Cyanobacteria ,01 natural sciences ,Mass Spectrometry ,Analytical Chemistry ,03 medical and health sciences ,chemistry.chemical_compound ,Metabolomics ,Methionine ,Bacterial Proteins ,Drug Discovery ,Microcystis aeruginosa ,IC50 ,Pharmacology ,chemistry.chemical_classification ,biology ,010405 organic chemistry ,Methionine sulfoxide ,Organic Chemistry ,biology.organism_classification ,0104 chemical sciences ,030104 developmental biology ,Enzyme ,Complementary and alternative medicine ,chemistry ,Biochemistry ,Molecular Medicine ,Peptides - Abstract
We report a mass-spectrometry-based metabolomics study of a laboratory-cultured strain of Microcystis aeruginosa (UTEX LB2385), which has led to the discovery of five peptides (1–5) belonging to the microginin class of linear cyanopeptides. The structures and configurations of these peptides were determined by spectroscopic analyses and chemical derivitization. The microginin peptides described herein are the first reported derivatives containing N-methyl methionine (1, 5) and N-methyl methionine sulfoxide (2–4). The two tripeptide microginin analogues (4, 5) identified represent the smallest members of this peptide family. Their angiotensin-converting enzyme (ACE) inhibitory activity was also investigated. Microginin 527 (4) was the most potent of the group, with an IC50 of 31 μM.
- Published
- 2018